PA
BLFS icon

Parallel Advisors’s BioLife Solutions BLFS Stock Holding History

Parallel Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,096
Closed -$15.1K – 3343
2023
Q3 		$15.1K Buy
1,096
+1,000
+1,042% +$15.8K ﹤0.01% 1995
2023
Q2 		$2.12K Sell
96
-107
-53% -$2.25K ﹤0.01% 2740
2023
Q1 		$4.42K Buy
203
+83
+69% +$1.87K ﹤0.01% 2456
2022
Q4 		$2.18K Buy
120
+24
+25% +$496 ﹤0.01% 2647
2022
Q3 		$2K Hold
96
– – ﹤0.01% 2597
2022
Q2 		$1K Buy
+96
New +$1.41K ﹤0.01% 2706
2021
Q2 		– Sell
-2,365
Closed -$85K – 2939
2021
Q1 		$85K Sell
2,365
-460
-16% -$18.2K ﹤0.01% 949
2020
Q4 		$113K Buy
+2,825
New +$96.3K 0.01% 769

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallel Advisors's BLFS Position: Q4 2023 in Review

Parallel Advisors sold out of BioLife Solutions (BLFS) in Q4 2023, closing a stake of 1,096 shares — an estimated $15.1K sold.

Parallel Advisors first reported a position in BLFS in Q4 2020 and held it in 8 quarters. The position peaked at $113K in Q4 2020. 140 funds tracked by Wall St. Rank hold BLFS as of Q4 2023.

  • Parallel Advisors reported no remaining BioLife Solutions position as of Q4 2023 after selling out during the quarter.
  • Parallel Advisors sold 1,096 BioLife Solutions shares in Q4 2023, an estimated $15.1K.
  • Parallel Advisors first reported a position in BioLife Solutions in Q4 2020 and held it in 8 quarters.
  • Parallel Advisors's BioLife Solutions position peaked at $113K in Q4 2020.
  • 140 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2023.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.